Concepedia

Effects of RGH-237 [N-{4-[4-(3-Aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an Orally Active, Selective Dopamine D3 Receptor Partial Agonist in Animal Models of Cocaine Abuse

István Gyertyán, Béla Kiss, Krisztina Gál, I. Laszlovszky, Attila Horváth, Larisza Gémesi, Katalin Sághy, Gabriella Pásztor, Mária Zájer, Margit Kapás,

Journal of Pharmacology and Experimental Therapeutics · 2006 · 33 citations · 34 references

DOI

References

34

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi Cheng, William H. Prusoff · Biochemical Pharmacology · 1973 · 12.8K citations

, , +8

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

Sean M Renock, Elaine G. Arrington, Louis A. Chiodo et al. · Neuropsychopharmacology · 2003 · 962 citations · Full text

, , +9

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Kevin D. Burris, Thaddeus F. Molski, Cen Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 914 citations

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

Maria Pilla, Sylvie Perachon, François Sautel et al. · Nature · 1999 · 568 citations

, , +11

[<sup>3</sup>H]8‐Hydroxy‐2‐(Di‐<i>n</i>‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat Brain

M.D. Hall, Salah El Mestikawy, M.B. Emerit et al. · Journal of Neurochemistry · 1985 · 459 citations